Trial Profile
A Randomised, Open-Label, Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Oral Doses of Candesartan Cilexetil in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Apr 2023
Price :
$35
*
At a glance
- Drugs Colestilan (Primary) ; Candesartan cilexetil
- Indications Hypercholesterolaemia; Hyperphosphataemia
- Focus Pharmacokinetics
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 08 Jan 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Nov 2013 New trial record